Search Mailing List Archives


Limit search to: Subject & Body Subject Author
Sort by: Reverse Sort
Limit to: All This Week Last Week This Month Last Month
Select Date Range     through    

[protege-owl] P3.4 build 130, SWRLTab, built in function normalizeSpace

Martin O'Connor martin.oconnor at stanford.edu
Mon May 5 16:29:57 PDT 2008


This is a bug. I have fixed it and the fix will be in the next release.

Martin

Liu, Richard wrote:

> Hello,
>
>  
>
> I seem to be having a problem with the swrlb:normalizeSpace built in 
> function.  It seems to insert blanks into words, as the examples below 
> show:
>
> ?report, ?report_title, ?ns_report_title
>
> Report_10, "Developmental and reproductive toxicology program 
> (National Toxicology Program, USA).", " D e v e l o p m e n t a l  a n 
> d  r e p r o d u c t i v e  t o x i c o l o g y  p r o g r a m  ( N a 
> t i o n a l  T o x i c o l o g y  P r o g r a m ,  U S A ) . "
>
> Report_11, "Summary of preclinical toxicity studies with Ro 05-4645 
> <coumermycin>.", " S u m m a r y  o f  p r e c l i n i c a l  t o x i 
> c i t y  s t u d i e s  w i t h  R o  0 5 - 4 6 4 5  < c o u m e r m y 
> c i n > . "
>
> Report_12, "A four week dermal toxicity study with Ro 22-8181/001 
> ointment (recombinant leukocyte A interferon ointment for topical use) 
> in rabbits.", " A  f o u r  w e e k  d e r m a l  t o x i c i t y  s t 
> u d y  w i t h  R o  2 2 - 8 1 8 1 / 0 0 1  o i n t m e n t  ( r e c o 
> m b i n a n t  l e u k o c y t e  A  i n t e r f e r o n  o i n t m e 
> n t  f o r  t o p i c a l  u s e )  i n  r a b b i t s . "
>
> Report_13, "Chronic toxicity study on the antimalarial combination Ro 
> 13-5112/003 <Fansimef> in rats; study performed by Hazleton 
> Laboratories Europe, Harrogate, Great Britain.", " C h r o n i c  t o 
> x i c i t y  s t u d y  o n  t h e  a n t i m a l a r i a l  c o m b i 
> n a t i o n  R o  1 3 - 5 1 1 2 / 0 0 3  < F a n s i m e f >  i n  r a 
> t s ;  s t u d y  p e r f o r m e d  b y  H a z l e t o n  L a b o r a 
> t o r i e s  E u r o p e ,  H a r r o g a t e ,  G r e a t  B r i t a 
> i n . "
>
> Report_14, "Hemolysis test of Ro 24-7375 (clinical formulation) on 
> human red blood cells", " H e m o l y s i s  t e s t  o f  R o  2 4 - 
> 7 3 7 5  ( c l i n i c a l  f o r m u l a t i o n )  o n  h u m a n  r 
> e d  b l o o d  c e l l s "
>
> Report_15, "TOXIZITAET VON BM 41.440 6 MONATS-VERSUCH AN HUNDEN ORAL", 
> " T O X I Z I T A E T  V O N  B M  4 1 . 4 4 0  6  M O N A T S - V E R 
> S U C H  A N  H U N D E N  O R A L "
>
> Report_16, "RO4390721 (5HT2c receptor agonist): Toxicogenomics 
> investigations on RO4390721 (006P03 (in vivo) and 019HT2c (in 
> vitro))", " R O 4 3 9 0 7 2 1  ( 5 H T 2 c  r e c e p t o r  a g o n i 
> s t ) :  T o x i c o g e n o m i c s  i n v e s t i g a t i o n s  o 
> n  R O 4 3 9 0 7 2 1  ( 0 0 6 P 0 3  ( i n  v i v o )  a n d  0 1 9 H 
> T 2 c  ( i n  v i t r o ) ) "
>
> Report_17, "Oseltamivir phosphate (Ro 64-07961002) for the treatment 
> of influenza in children: Written toxicology summary", " O s e l t a m 
> i v i r  p h o s p h a t e  ( R o  6 4 - 0 7 9 6 1 0 0 2 )  f o r  t h 
> e  t r e a t m e n t  o f  i n f l u e n z a  i n  c h i l d r e n :  
> W r i t t e n  t o x i c o l o g y  s u m m a r y "
>
> Report_1_Test, "Clinical Report", " C l i n i c a l  R e p o r t "
>
> Report_2_Test, "Non clinical Report", " N o n  c l i n i c a l  R e p 
> o r t "
>
> Report_3_Test, "Non Clinical Report", " N o n  C l i n i c a l  R e p 
> o r t "
>
> Report_42, "The effect of beta-carotene in a tumorigenicity study in 
> mice (dietary administration during life time); a two year toxicity 
> study performed at Huntingdon Research Centre, England.", " T h e  e f 
> f e c t  o f  b e t a - c a r o t e n e  i n  a  t u m o r i g e n i c 
> i t y  s t u d y  i n  m i c e  ( d i e t a r y  a d m i n i s t r a t 
> i o n  d u r i n g  l i f e  t i m e ) ;  a  t w o  y e a r  t o x i c 
> i t y  s t u d y  p e r f o r m e d  a t  H u n t i n g d o n  R e s e 
> a r c h  C e n t r e ,  E n g l a n d . "
>
> Report_43, "The effect of beta-carotene in a long-term toxicity study 
> in dogs (dietary administration for 104 weeks); study performed at the 
> Huntingdon Research Centre, England.", " T h e  e f f e c t  o f  b e 
> t a - c a r o t e n e  i n  a  l o n g - t e r m  t o x i c i t y  s t 
> u d y  i n  d o g s  ( d i e t a r y  a d m i n i s t r a t i o n  f o 
> r  1 0 4  w e e k s ) ;  s t u d y  p e r f o r m e d  a t  t h e  H u 
> n t i n g d o n  R e s e a r c h  C e n t r e ,  E n g l a n d . "
>
> Report_52, "A 78 week interim report for a 2 year oral (dietary admix) 
> toxicity/ carcinogenicity study in rats with Ro 21-3981/001. Volume I 
> - III.", " A  7 8  w e e k  i n t e r i m  r e p o r t  f o r  a  2  y 
> e a r  o r a l  ( d i e t a r y  a d m i x )  t o x i c i t y /  c a r 
> c i n o g e n i c i t y  s t u d y  i n  r a t s  w i t h  R o  2 1 - 
> 3 9 8 1 / 0 0 1 .  V o l u m e  I  -  I I I . "
>
> Report_6_Test, "This is a non clinical report", " T h i s  i s  a  n o 
> n  c l i n i c a l  r e p o r t "
>
> Report_7_Test, "This is a clinical report", " T h i s  i s  a  c l i n 
> i c a l  r e p o r t "
>
> Report_9, "The reproductive toxicology of various aromatic retinoids 
> in the mouse, rat, and rabbit. A summary of results from Seg. I, II 
> and III studies.", " T h e  r e p r o d u c t i v e  t o x i c o l o g 
> y  o f  v a r i o u s  a r o m a t i c  r e t i n o i d s  i n  t h e  
> m o u s e ,  r a t ,  a n d  r a b b i t .  A  s u m m a r y  o f  r e 
> s u l t s  f r o m  S e g .  I ,  I I  a n d  I I I  s t u d i e s . "
>
> Does anybody have an idea what I might be doing wrong?
>
> Regards,
>
> ____________________________
>
> *Richard Liu*
>
> Group Research Information
>
> Scientific Information Resources
>
> F. Hoffmann-La Roche Ltd.
>
> PXIBR
>
> Bldg. 092/6.01
>
> CH-4070 Basel, Switzerland
>
> Phone: +41 (0)61 687 92 14
>
> FAX: +41 (0)61 688 95 70
>
> richard.liu at roche.com <mailto:richard.liu at roche.com>
>
> *Confidentiality Note:* This message is intended only for the use of 
> the named recipient(s) and may contain confidential and/or privileged 
> information. If you are not the intended recipient, please contact the 
> sender and delete this message. Any unauthorized use of the 
> information contained in this message is prohibited.
>
>  
>
>------------------------------------------------------------------------
>
>_______________________________________________
>protege-owl mailing list
>protege-owl at lists.stanford.edu
>https://mailman.stanford.edu/mailman/listinfo/protege-owl
>
>Instructions for unsubscribing: http://protege.stanford.edu/doc/faq.html#01a.03 
>  
>




More information about the protege-owl mailing list